Trending...
- Bloomington: City Farmers' Market Accepting Proposals from Food and Beverage Artisans, Applications from Farmers and Growers, for Vending Spaces at 2021 Saturday Market
- Bloomington: Donation to Fund Recreation Amenities at Goat Farm Property
- Merchants Capital Enters Tax Credit Equity Market with Launch of Syndication Platform, Closes First Fund
Science Leader in the Testing of Flea and Tick Borne Illness Introduces the Nanotrap® Urine Test for Lyme Borreliosis
DURHAM, N.C. - IndianaStop -- Galaxy Diagnostics, Inc., the science leader in sample enrichment powered testing solutions for elusive flea and tick-borne pathogens, today announced the launch of the Nanotrap® Urine Test for Lyme Borreliosis. This urine-based Lyme antigen test provides the most sensitive direct detection of Borrelia burgdorferi infection at all stages of the disease. The test provides advantages antibody testing does not, namely:
Published data shows that the Nanotrap Urine Test is very effective for confirmation of early stage Lyme borreliosis in patients with EM rashes (24/24). Galaxy validation data (unpublished) shows that the Nanotrap® Urine Test will often confirm active infection in patients with negative TTT results. Further research is needed to confirm clinical utility for other presentations of Lyme borreliosis, including Lyme arthritis, Lyme carditis, and neuroborreliosis.
More on indianastop.com
"The addition of the Nanotrap® test aligns with our mission to bring the most scientifically advanced sample enrichment technologies and diagnostic advances to the forefront of flea and tick borne disease", said Galaxy CEO Amanda Elam. "Lyme disease is the fastest growing tick-borne illness in the United States. We are committed to improving the standard of care around detection of these elusive, low abundance pathogens to ensure better patient care for millions globally."
Galaxy advocates for a new standard of care in Lyme Borreliosis testing and recommends a combination diagnostic protocol with Nanotrap® Urine test to confirm active infection and the CDC recommended TTT to detect the presence of antibodies.
You can order here and learn more at galaxydx.com.
About Galaxy Diagnostics
Galaxy Diagnostics is a privately held medical laboratory located in Research Triangle Park offering the only testing solutions powered by revolutionary sample enrichment technologies for elusive flea and tick borne pathogens. The company's mission is to "Go Beyond" the limits of conventional detection by driving scientific innovation, creating new clinical knowledge through research and publication, and providing medical education and excellent customer support to healthcare providers, veterinarians, patients, and research customers in this important area of emerging infectious disease.
More on indianastop.com
About Ceres Nanosciences
Ceres Nanosciences is a privately held company, located in Northern Virginia, focused on incorporating its novel Nanotrap® particle technology into a range of diagnostic products and workflows. The Nanotrap® particle technology can improve diagnostic testing by capturing, concentrating, and preserving low abundance analytes from biological samples. The Nanotrap® particle technology was developed with support from the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency (DTRA), and the Commonwealth of Virginia.
- Identifies positive cases missed by CDC-recommended Two-Tiered Testing (TTT)
- Reduces concern for false positive results via direct detection of OspA proteins
- Uses easy-to-collect urine sample
Published data shows that the Nanotrap Urine Test is very effective for confirmation of early stage Lyme borreliosis in patients with EM rashes (24/24). Galaxy validation data (unpublished) shows that the Nanotrap® Urine Test will often confirm active infection in patients with negative TTT results. Further research is needed to confirm clinical utility for other presentations of Lyme borreliosis, including Lyme arthritis, Lyme carditis, and neuroborreliosis.
More on indianastop.com
- Syxsense Announces the Release of Syxsense Cortex, A Next-Generation, Visual IT and Security Management Process Automation Solution
- Allison Transmission Receives 2019 Master of Quality Award from Daimler Trucks North America
- Top 5 Things Companies Can Do Today To Set Themselves Up For Success in 2021
- New data show treatment with Lilly's neutralizing antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) together reduced risk of COVID-19 hospitalizations and death by 70 percent
- Gembah Sees Exponential Growth Year-Over-Year as eCommerce Industry Thrives
"The addition of the Nanotrap® test aligns with our mission to bring the most scientifically advanced sample enrichment technologies and diagnostic advances to the forefront of flea and tick borne disease", said Galaxy CEO Amanda Elam. "Lyme disease is the fastest growing tick-borne illness in the United States. We are committed to improving the standard of care around detection of these elusive, low abundance pathogens to ensure better patient care for millions globally."
Galaxy advocates for a new standard of care in Lyme Borreliosis testing and recommends a combination diagnostic protocol with Nanotrap® Urine test to confirm active infection and the CDC recommended TTT to detect the presence of antibodies.
You can order here and learn more at galaxydx.com.
About Galaxy Diagnostics
Galaxy Diagnostics is a privately held medical laboratory located in Research Triangle Park offering the only testing solutions powered by revolutionary sample enrichment technologies for elusive flea and tick borne pathogens. The company's mission is to "Go Beyond" the limits of conventional detection by driving scientific innovation, creating new clinical knowledge through research and publication, and providing medical education and excellent customer support to healthcare providers, veterinarians, patients, and research customers in this important area of emerging infectious disease.
More on indianastop.com
- Oliver Winery & Vineyards Partners with NexPhase Capital to Accelerate Future Growth
- Beautiful black ebony Bosendorfer grand piano hammers for $53,125 at Ripley Auctions, January 16th
- Evansville: Mayor Winnecke Proposes Commission on Food Security
- MC Companies and Move For Hunger Announce Collaborative Effort to Fight Hunger Nationwide
- Simply The Best Digital To Provide Digital Marketing Services to Urgent Home Care - Palm Beach's Leading Home Health Service
About Ceres Nanosciences
Ceres Nanosciences is a privately held company, located in Northern Virginia, focused on incorporating its novel Nanotrap® particle technology into a range of diagnostic products and workflows. The Nanotrap® particle technology can improve diagnostic testing by capturing, concentrating, and preserving low abundance analytes from biological samples. The Nanotrap® particle technology was developed with support from the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency (DTRA), and the Commonwealth of Virginia.
Source: Galaxy Diagnostics, Inc.
0 Comments
Latest on indianastop.com
- Rustic Deco Launches B2B Wholesale Furniture Website
- New Publications Provide Healthcare Providers Practical Strategies to Help Patients Reduce Added Sugars in the New Year
- Black Diamond Pr & Sport Management Firm Announces Representation Of The Indianapolis Enforcers
- TRIMEDX Awarded SOC 2 Type 2 and International Organization for Standardization's World-Class Information Management Security Certifications
- IOTech names Gavin Hunter as VP of global marketing
- Introducing BIAMI.IO Apps Framework
- City Streaming TV, a Streaming Television Inc Network Launches, bringing Community and Faith Leaders into local TV's, At No Cost
- Merchants Capital Enters Tax Credit Equity Market with Launch of Syndication Platform, Closes First Fund
- BoatDealers.ca Surges with Record Traffic in 2020
- 'Aesthetic Institute of Massachusetts' Announces Rebranding to 'Aesthetic Mentor'
- The American Legion seeks entries for Fourth Estate Awards in print, broadcast and online media
- OCC Adopts Final Rule Requiring Large Banks to Provide Fair Access to Banking Services
- The Antenna Company Announces Venture Debt Financing Agreement with Brabant Development Agency (BOM)
- Pro Paint & Finish Wins Angie's List Super Service Award 2020
- Code18 Interactive Launches New Websites for Balmex and Balmex Adult
- The Atlas Group adds Corbin Raines to their list of professional property managers
- Innovative Portfolios Posts High Morningstar Rankings for 2020 Year-End
- Bloomington: City Farmers' Market Accepting Proposals from Food and Beverage Artisans, Applications from Farmers and Growers, for Vending Spaces at 2021 Saturday Market
- Stephen Dybwad Named Contributing Author for ThinkAdvisor
- Latino Leaders Network to Honor Tucson Mayor Regina Romero with the Antonio Villaraigosa Leadership Award at the 34th Tribute to Mayors